Stock analysts at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock. Pulmatrix Price Performance Pulmatrix stock opened at $2.08 on Wednesday. The stock has a market cap of $7.59 million, a price-to-earnings […]